Clinical trial · Interventional
Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts
Laser Versus Cryotherapy for the Treatment of Recalcitrant Warts: a Randomised Controlled Trial
NCT05616078CI-TRIAL-00062181unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To evaluate whether laser was superior to cryotherapy for recalcitrant warts
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Warts | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cryotherapy | Other | — | UNRESOLVED |
| laser treatment | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- laser treatment
- description
- LP-Nd:YAG laser treatment
- interventionNames
- Other: laser treatment
- type
- ACTIVE_COMPARATOR
- label
- cryotherapy
- description
- cryotherapy with liquid nitrogen
- interventionNames
- Other: cryotherapy
Primary outcomes (1)
- measure
- cure rate at 16 weeks
- timeFrame
- 16 weeks since the initial treatment
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with HPV2/27/57-induced recalcitrant warts, including periungualor mosaic warts, common or plantar warts with a duration of longer than 1 year, and common or plantar warts previously received no more than two sessions of cryotherapy * Total number of warts is ≤10 . * Aged 18 years or older. Exclusion Criteria: * Patients are currently participating in another trial for the treatment of cutaneous warts. * Patients have taken immunosuppressant drugs (such as oral corticosteroids) during the past three months. * Patients have impaired healing eg due to diabetes, vitamin A deficiency, hyperthyroidism and hypothyroidism. * Patients have autoimmune diseases (such as systemic lupus erythematosus, dermatomyositis, scleroderma or other diseases). * Patients are pregnant or ready for pregnancies or breast-feeding. * Patients have cold intolerance (such as cold urticaria, cryoglobulinaemia, cold agglutinin syndrome or Raynaud's syndrome). * Patients have local pain intolerance. * Patients have local hypoesthesia. * Patients are unable to tolerate laser or cryotherapy.
References
Publications (0)
Data not yet available
No reference posted for this study.